chartexchange

Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)

GlobeNewswire Inc. | Oct 28, 2026 8:19 PM EDT

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided its activity report for the first fiscal quarter ended September 30, 2026.

Read original article